Pigment Cell & Melanoma Research

Papers
(The median citation count of Pigment Cell & Melanoma Research is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Acral lentiginous melanoma: Basic facts, biological characteristics and research perspectives of an understudied disease65
An update on Vitiligo pathogenesis60
Management of hyperpigmentation: Current treatments and emerging therapies44
Rab GTPases: Key players in melanosome biogenesis, transport, and transfer42
Chemical and biochemical control of skin pigmentation with special emphasis on mixed melanogenesis38
The evolution of human skin pigmentation involved the interactions of genetic, environmental, and cultural variables34
Participation of keratinocyte‐ and fibroblast‐derived factors in melanocyte homeostasis, the response to UV, and pigmentary disorders32
Nicotinamide N‐methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines30
The role of ferroptosis in melanoma28
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation27
Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse27
The fate of melanocyte: Mechanisms of cell death in vitiligo26
Alterations of the pigmentation system in the aging process26
Strategies in DNA vaccine for melanoma cancer24
The tumour immune landscape and its implications in cutaneous melanoma23
The role of technology in melanoma screening and diagnosis23
First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma22
Cyclic adenosine monophosphate (cAMP) signaling in melanocyte pigmentation and melanomagenesis21
The structure and function of the mouse tyrosinase locus21
Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma20
NRF2‐dependent stress defense in tumor antioxidant control and immune evasion19
The effect of aging and antioxidants on photoreactivity and phototoxicity of human melanosomes: An in vitro study18
Support for increased cardiovascular risk in non‐segmental vitiligo among Egyptians: A hospital‐based, case–control study16
Dark cyclobutane pyrimidine dimers are formed in the epidermis of Fitzpatrick skin types I/II and VI in vivo after exposure to solar‐simulated radiation16
Dhh‐expressing Schwann cell precursors contribute to skin and cochlear melanocytes, but not to vestibular melanocytes15
Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells15
HPS11 and OCA8: Two new types of albinism associated with mutations in BLOC1S5 and DCT genes15
Novel three‐way complex rearrangement of TRPM1‐PUM1LCK in a case of agminated Spitz nevi arising in a giant congenital hyperpigmented macule15
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment14
Current landscape of Oculocutaneous Albinism in Japan14
Human TYRP1: Two functions for a single gene?14
The MITF regulatory network in melanoma14
A Focused review on the pathophysiology of post‐inflammatory hyperpigmentation14
Vitiligo: Translational research and effective therapeutic strategies13
Artificial intelligence and melanoma: A comprehensive review of clinical, dermoscopic, and histologic applications13
User guide to MiT‐TFE isoforms and post‐translational modifications13
Altered expression of ferroptosis markers and iron metabolism reveals a potential role of ferroptosis in vitiligo12
The unfolded protein and integrated stress response in melanoma and vitiligo12
The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma12
Premature senescence in human melanocytes after exposure to solar UVR: An exosome and UV‐miRNA connection12
Phenotypic plasticity of melanocytes derived from human adult skin11
Speed rate (SR) as a new dynamic index of melanoma behavior11
Endothelin signaling promotes melanoma tumorigenesis driven by constitutively active GNAQ11
Non‐invasive optical biopsy by multiphoton microscopy identifies the live morphology of common melanocytic nevi11
RASGRF2 gene fusions identified in a variety of melanocytic lesions with distinct morphological features11
Immunotherapy for older patients with melanoma: From darkness to light?11
New insights into the pathogenesis of Hermansky–Pudlak syndrome10
Analysis of CRISPR‐Cas9 screens identifies genetic dependencies in melanoma10
Melanin‐concentrating hormone like and somatolactin. A teleost‐specific hypothalamic‐hypophyseal axis system linking physiological and morphological pigmentation10
The role of melanocytes in the human choroidal microenvironment and inflammation: Insights from the transcriptome10
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transfer10
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)10
Genetic variants and mutational spectrum of Chinese Hermansky–Pudlak syndrome patients9
Multiple desmoplastic Spitz nevi with BRAF fusions in a patient with ring chromosome 7 syndrome9
Acral lentiginous melanoma—Population, treatment, and survival using the NCDB from 2004 to 20159
Drosophila yellow‐h encodes dopaminechrome tautomerase: A new enzyme in the eumelanin biosynthetic pathway9
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families9
CD147 regulates melanoma metastasis via the NFAT1‐MMP‐9 pathway9
Genomic and signalling pathway characterization of the NZM panel of melanoma cell lines: A valuable model for studying the impact of genetic diversity in melanoma9
Transcriptomic analysis and ednrb expression in cochlear intermediate cells reveal developmental differences between inner ear and skin melanocytes8
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma8
Antihypertensives and melanoma: An updated review8
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation8
Recurrent co‐alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis8
The delicate relation between melanocytes and skin immunity: A game of hide and seek8
Consideration of possible effects of vitamin D on established cancer, with reference to malignant melanoma8
Establishment of a mouse model for post‐inflammatory hyperpigmentation7
The feather pattern autosomal barring in chicken is strongly associated with segregation at the MC1R locus7
Volar location and degree of pigmentation are associated with poor survival and first metastasis pattern in acral melanoma7
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance7
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma7
Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy7
Heme oxygenase promotes B‐Raf‐dependent melanosphere formation7
Connexins in melanoma: Potential role of Cx46 in its aggressiveness7
Germline loss‐of‐function variants in MBD4 are rare in Finnish patients with uveal melanoma7
The impaired unfolded protein‐premelanosome protein and transient receptor potential channels‐autophagy axes in apoptotic melanocytes in vitiligo7
A novel BLOC1S5‐related HPS‐11 patient and zebrafish with bloc1s5 disruption6
Tape stripping and lipidomics reveal skin surface lipid abnormity in female melasma6
Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation‐induced canities6
Melanocortin‐1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium‐to‐giant congenital melanocytic nevi6
Investigating DNA methylation as a potential mediator between pigmentation genes, pigmentary traits and skin cancer6
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study6
Eosinophils and melanoma: Implications for immunotherapy6
Induced pluripotent stem cell‐derived myeloid cells expressing OX40 ligand amplify antigen‐specific T cells in advanced melanoma6
Pharmacologic manipulation of skin pigmentation5
Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes5
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro‐tumourigenicity5
Primary tumor characteristics and next‐generation sequencing mutations as biomarkers for melanoma immunotherapy response5
Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities5
Interferon‐gamma induces melanogenesis via post‐translational regulation of tyrosinase5
Abrogation of RAB27A expression transiently affects melanoma cell proliferation5
Advancements in melanoma cancer metastasis models5
Systematic review and meta‐analysis of genomic alterations in acral melanoma5
Genome‐wide association study identifies CDH13 as a susceptibility gene for rhododendrol‐induced leukoderma5
Non‐Steroidal Anti‐Inflammatory Drugs (NSAIDs) sensitize melanoma cells to MEK inhibition and inhibit metastasis and relapse by inducing degradation of AXL5
Presence and the roles of IL‐9/Th9 axis in vitiligo5
A prospective observational study to sequentially determine the dermoscopic features of vitiligo and its association with disease activity in patients on medical treatment4
Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma4
Transient activation of tumoral DNA damage tolerance pathway coupled with immune checkpoint blockade exerts durable tumor regression in mouse melanoma4
Trained immunity in the pathogenesis of vitiligo4
Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment4
NRASQ61K melanoma tumor formation is reduced by p38‐MAPK14 activation in zebrafish models and NRAS‐mutated human melanoma cells4
Novel variants in the BLOC1S3 gene in patients presenting a mild form of Hermansky–Pudlak syndrome4
A B‐cell or a key player? The different roles of B‐cells and antibodies in melanoma4
Establishment of cultured primary acral melanoma cells and animal models for Chinese patients4
Myron Gordon Award paper: Microbes, T‐cell diversity and pigmentation4
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 64
Varicella‐zoster virus in actively spreading segmental vitiligo skin: Pathological, immunochemical, and ultrastructural findings (a first and preliminary study)4
Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population3
Cell‐intrinsic melanin fails to protect melanocytes from ultraviolet‐mutagenesis in the absence of epidermal melanin3
Let’s talk about sex: A biological variable in immune response against melanoma3
Neutrophil‐to‐eosinophil ratio as a biomarker for clinical outcomes in advanced stage melanoma patients treated with anti‐PD‐1 therapy3
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features3
NR2F1 regulates a Schwann cell precursor‐vs‐melanocyte cell fate switch in a mouse model of Waardenburg syndrome type IV3
Abstracts3
Generation of Pmel‐dependent conditional and inducible Cre‐driver mouse line for melanocytic‐targeted gene manipulation3
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model3
Toxicity and response to ipilimumab and nivolumab in older patients with metastatic melanoma: A multicentre retrospective analysis3
Increased anti‐oxidative action compensates for collagen tissue degeneration in vitiligo dermis3
Mitochondrial DNA‐depleter mouse as a model to study human pigmentary skin disorders3
Melanoma toolkit for early detection for primary care providers: A pilot study3
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines3
3
MITF deficiency and oncogenic GNAQ each promote proliferation programs in zebrafish melanocyte lineage cells3
Image analysis systems to calculate the surface area of vitiligo lesions: A systematic review of measurement properties3
Seasonal variation in effect of anti‐PD‐1 initiation on overall survival among patients with advanced melanoma3
Neratinib kills B‐RAF V600E melanoma via ROS‐dependent autophagosome formation and death receptor signaling3
Making a melanoma: Molecular and cellular changes underlying melanoma initiation3
Epigenetic and pharmacological control of pigmentation via Bromodomain Protein 9 (BRD9)2
Influence of germline genetic variants on dermoscopic features of melanoma2
2
B7‐H3 drives immunosuppression and Co‐targeting with CD47 is a new therapeutic strategy in β‐catenin activated melanomas2
Morphological evolution in melanoma in situ using revised pattern analysis2
Melanoma literacy among the general population of three western US states2
Protein‐based classification of melanoma differentiation subtypes2
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment2
Leptomeningeal disease in melanoma: An update on the developments in pathophysiology and clinical care2
Role of serine 365 in BRAF V600E sensitivity to RAF inhibition2
19th International Congress of the Society for Melanoma Research2
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants2
2
RAC1mutation is not a predictive biomarker for PI3’‐kinase‐β‐selective pathway‐targeted therapy2
New insights into segmental vitiligo: A clinical and immunological comparison with nonsegmental vitiligo2
2
Intragenic NF1 deletions in sinonasal mucosal malignant melanoma2
Donskoy cats as a new model of oculocutaneous albinism with the identification of a splice‐site variant in HermanskyPudlak Syndrome 5 gene2
Dysbiosis of skin microbiome in melasma patients2
BMI1 is required for melanocyte stem cell maintenance and hair pigmentation2
Small extracellular vesicle‐based human melanocyte and melanoma signature1
Perspectives on the nanocarriers with miRNAs for targeting melanoma stemness through epigenetic regulation1
Undereducation is afoot: Assessing the lack of acral lentiginous melanoma educational materials for skin of color1
Genetic analysis of multiple primary melanomas arising within the boundaries of congenital nevi depigmentosa1
A twenty year perspective on melanoma therapy1
1
Dynamic regulation of chromatin accessibility during melanocyte stem cell activation1
Clinicopathological features and associations in a series of South African acral melanomas1
AP‐3 complex subunit delta gene, ap3d1, regulates melanogenesis and melanophore survival via autophagy in zebrafish (Danio rerio)1
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy1
Diversity, equity, and inclusion in the melanoma research community1
MITF E318K: A rare homozygous case with multiple primary melanoma1
Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line1
Special issue: “Biology of skin pigmentation and pigmentary diseases”1
Optimisation of skin phototype classification1
Seasonal variation of anti‐PD‐1 outcome in melanoma—Results from a Dutch patient cohort1
B6‐Dct‐H2BGFP bitransgenic mice: A standardized mouse model for in vivo characterization of melanocyte development and stem cell differentiation1
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis1
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism1
Senescent no more1
The MFSD12 p.Tyr182His common variant is sufficient to alter mouse agouti coat color1
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo1
The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment1
Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK)1
Histopathologic abundance of pigmentation correlates with disease‐specific survival in malignant melanoma but is not independent of current AJCC pT stage1
Immune‐modulatory effects of lenalidomide inhibited the progression of lesions in a vitiligo mouse model1
Oncogenic properties via MAPK signaling of the SOX5‐RAF1 fusion gene identified in a wild‐typeNRAS/BRAF giant congenital nevus1
1
Zebrafish as a new model for rhododendrol‐induced leukoderma1
Identification and functional assays of single‐nucleotide variants of opsins genes in melanocytic tumors1
1
0.024698972702026